Pyxis Oncology, Inc. (PYXS) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts PYXS Hot Sheet
Join SI Premium – FREE
Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q3 EPS of ($0.35), $0.01 worse than the analyst estimate of ($0.34).
For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Is Said to Weigh Delaying North America Gold IPO to 2027 - Bloomberg
- FuelCell Energy (FCEL) Misses Q3 EPS by 24c
- Ollie's Bargain Outlet (OLLI) Tops Q2 EPS by 28c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
